This post was commissioned on June 10, 2008, and it was categorized as Company Shakeups.
Feel free to leave a comment below. Eben loves comments.
You may also subscribe to comments through this RSS Comments feed or trackback here.
The Israeli generic drug maker, known for its aggressive tactics is getting a taste of its own medicine if Pittsburgh based, Mylan has anything to say about it (I can’t get enough of the: “taste of its own medicine line”).
TEVA markets a proprietary, branded drug for MS called glatiramer acetate (COPAXONE), sold $1.7B worth of the drug last year and is on pace to top $2B this year. The patent doesn’t expire until 2014 but Mylan (after signing an agreement with the India based NATCO) is threating sales in the US, EU, Canada and Japan, among others.
There is still a long road to market due to the whole pesky patent issue, but I’m sure we’ll soon see a challenge and some interesting fireworks.
In conclusion: TEVA gets a taste of its own medicine.
Eben is a highly caffeinated business development associate at a small, cash sensitive pharmaceutical company somewhere in Massachusetts. He enjoys cliche-less banter, compartmentalization, non-equilibrium thermodynamics and NPV analysis. Agree or disagree with what he's posted? He encourages comments.
If one were so inclined, one could follow him at any of these fine web 2.0 establishments:
Feel free to leave a comment below. Eben loves comments.
You may also subscribe to comments through this RSS Comments feed or trackback here.
Mylan hasn't said anything, exactly... so, neither am I but you don't secure world-wide distribution rights 8 years in advance without trying to exercise them, right?. My guess is that mylan with do something eventually (before the patent expires) and I was simply commenting on the duality of a primarily generic drug maker having the revenue of their only branded medicine eaten away by a generic brand.
Add New Comment
Viewing 2 Comments
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Add New Comment
Trackbacks
(Trackback URL)